Argo advises Heran Partners on the launch of their second HealthTech fund

Argo supported Heran Partners with the structuring and legal documentation of their second HealthTech fund, which raised €90 million, aiming for a final close of €120 million.

Heran Partners is a Belgian venture capital firm focused on early-stage investments in European medtech and healthtech companies. This second fund builds on the success of its predecessor, which backed 15 companies and completed several high-profile exits.

With support from the European Investment Fund (EIF), PMV, KU Leuven, BNP Paribas Fortis, and a diverse group of entrepreneurial investors, Heran HealthTech Fund II seeks to invest in enabling technologies that make healthcare smarter, more efficient, and more scalable. The fund already made its first investment in Pharmacelera, a Spanish AI-driven drug discovery platform.

Argo assisted Heran Partners with all legal and tax aspects of the fund set-up.